The Cardius 3 XPO triple-head camera features fourth- generation High Definition Solid-State Detectors (HDSD) that offer up to a 38 percent greater image acquisition efficiency for cardiac SPECT over dual-head systems and a patient positioning system that permits imaging patients weighing up to 500 pounds.

Cardiac Science Corp. has launched HeartCentrix, a software solution that enables its diagnostic stress, Holter and electrocardiography devices to communicate seamlessly with physician office-based electronic medical record (EMR) systems.

St. Jude Medical Inc. says it has received FDA approval of a new cardiac rhythm management device designed to help physicians manage heart failure (HF) patients, including patients who have or may develop atrial fibrillation (AF).

When used in conjunction with the ev3 embolic protection device, ev3’s PROTÉGÉ RX Carotid Stent has been FDA cleared for the treatment of carotid artery disease in patients who are at high-risk for adverse events from carotid artery surgery. The cleatance was supported by the CREATE (Carotid Revascularization with ev3 Inc.

Pfizer says the FDA has approved the company’s Lipitor (atorvastatin calcium) Tablets to reduce the risk of nonfatal heart attacks, fatal and non-fatal strokes, certain types of heart surgery, hospitalization for heart failure, and chest pain in patients with heart disease — making Lipitor the first cholesterol-lowering medication to receive FDA approval for the reduction of the risk of hospit

The NICO2 Respiratory Profile Monitor is designed to monitor the patient side of the breathing circuit. NICO2 goes beyond conventional capnography to measure breath-by-breath volumetric CO2 and takes the guesswork out of ventilation management from setup to weaning.

Exercise Tolerance Testing (ETT) is a diagnostic tool consisting of the RHE cycle, that is used in conjunction with scientifically validated exercise testing protocols to create a more accurate, sensitive and comfortable test, according to the company.